SPOTLIGHT: Red Cross jabs back at J&J over trademark


The American Red Cross claims Johnson & Johnson has been using their twin trademark inappropriately. In the charity's response to J&J's trademark-infringement lawsuit, the Red Cross also says the feds have long recognized its right to sell Red-Cross branded products that support its mission. Release

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.